1 / 5

Kuala Lumpur, J uly 2nd 2013

Kuala Lumpur, J uly 2nd 2013. The ANRS International VISCONTI Post Treatment Controller Cohort. OBJECTIVES. To build an international cohort of Post Treatment Controllers in order to : Uncover mechanisms underlying viral control, i.e. HIV remission

phuc
Download Presentation

Kuala Lumpur, J uly 2nd 2013

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Kuala Lumpur, July 2nd 2013 The ANRS International VISCONTI Post Treatment Controller Cohort

  2. OBJECTIVES • To build an international cohort of Post Treatment Controllers in order to : • Uncover mechanisms underlying viral control, i.e. HIV remission • Identify predictive markers associated with viral control after treatment interruption • Main Outcome: To identify patients in whom HAART could be safely interrupted

  3. To increase the number of cases: • To describe epidemiological and clinical characteristics of PTC • Age, sex, PHI, Time of treatment initiation, treatment duration, ARV combinations used, transmission group… • To describe Virological and Immunological characteristics • Analyse and quantification of the cellular and anatomical reservoirs • Viral properties and interactions between viral and cellular proteins • Innate and adaptive immunity, antibody response…. • To Compare to other cohortsof patients at different stages of HIV infection: PHI, HIV controllers, Chronic patients, patients on HAART…

  4. Methodology • Inclusion criteria • Treatment initiation with VL >2000 HIV-RNA copies/ml, whatever the timing of infection • Treatment for more than 12 months • Viral control after Treatment interruption below 400 copies/ml for at least 12 months • Data collected once a year

  5. General organisation • Funded and organized : ANRS • International Steering Committee • International Scientific Committee • PI : AsierSaez-Cirionand Laurent Hocqueloux • International recruitment: Two levels of inclusion 1 – with Clinical and epidemiological data 2 – with Clinical and epidemiological data + BIOBANK CONTACT : visconti@anrs.fr

More Related